MedPath

Gene analysis associated with short stature and growth hormone responsiveness

Not Applicable
Conditions
famirial short stature, idopathic short stature, Noonan syndrome, and good/poor respoders of growth hormone therapy
Registration Number
JPRN-UMIN000000529
Lead Sponsor
Keio University, School of Medicine
Brief Summary

We identified heterozygous NPR2 mutations in 2% of Japanese patients with short stature. Our in vitro findings indicate that NPR2 mutations have a dominant negative effect, and their dominant-negative mechanisms vary corresponding to the molecular pathogenesis of the mutations. (J Clin Endocrinol Metab 99: E713, 2014)

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
100
Inclusion Criteria

Not provided

Exclusion Criteria

none

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
gene analysis and functional assay
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath